CheckMyRecalls

ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal…

ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal Solution

Published
12 Feb 2025
Units affected
44,397 amber glass vials
Agency
FDA
Country
United States

The hazard

Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Adrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-103-01

Brand / company
ENDO USA, Inc.
Codes / lots
All lots within expiry
Distribution
USA nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.